Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-048504
Filing Date
2025-05-14
Accepted
2025-05-14 16:06:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2514515d1_defa14a.htm DEFA14A 12554
  Complete submission text file 0001104659-25-048504.txt   13525
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40236 | Film No.: 25945384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)